Giulia Magini
YOU?
Author Swipe
View article: Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib
Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib Open
Background: Transarterial chemoembolisation (TACE) and radioembolisation (TARE) can lead to the deterioration of liver function, especially in cases of a high tumour burden, potentially lessening the benefits of subsequent systemic treatme…
View article: Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation
Prognostic scores for ursodeoxycholic acid-treated patients predict graft loss and mortality in recurrent primary biliary cholangitis after liver transplantation Open
View article: A false positive hair ethylglucuronide dosage in an alcohol abstinent patient after liver transplantation: a case report
A false positive hair ethylglucuronide dosage in an alcohol abstinent patient after liver transplantation: a case report Open
The use of direct alcohol biomarkers (ethylglucuronide and phosphatidylethanol) has recently been implemented in a clinical setting. Due to their low alcohol detection threshold, high sensitivity, and specificity, these tools are very usef…
View article: Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib Open
Antiangiogenics are associated with an increased risk of major adverse cardiac and cerebrovascular events (MACE). The identification of at-risk subjects is relevant in the case of hepatocellular carcinoma (HCC), for which anti-angiogenic T…
View article: Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centers
Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centers Open
Background and Aims: Management of Budd-Chiari syndrome (BCS) has improved over the last decades. The main aim was to evaluate the contemporary post-liver transplant (post-LT) outcomes in Europe. Approach and Results: Data from all patient…
View article: Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy Open
Background: Intermediate-stage hepatocellular carcinoma (BCLC B HCC) occurs in a heterogeneous group of patients and can be addressed with a wide spectrum of treatments. Consequently, survival significantly varies among patients. In recent…
View article: Prognostic impact of metastatic site in patients receiving first-line sorafenib therapy for advanced hepatocellular carcinoma
Prognostic impact of metastatic site in patients receiving first-line sorafenib therapy for advanced hepatocellular carcinoma Open
View article: Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma Open
Extrahepatic spread is a well-known negative prognostic factor in patients with advanced hepatocellular carcinoma (HCC). The prognostic role of different metastatic sites and their response rate to systemic treatment is still being debated…
View article: Utilization of livers donated after circulatory death for transplantation – An international comparison
Utilization of livers donated after circulatory death for transplantation – An international comparison Open
View article: Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis Open
View article: AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool Open
View article: Use of statins after liver transplantation is associated with improved survival: results of a nationwide study
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study Open
Summary Background There is limited information on the effects of statins on the outcomes of liver transplantation (LT), regarding either their use by LT recipients or donors. Aim To analyse the association between statin exposure and reci…
View article: Use of statins after liver transplantation is associated with improved survival: results of a nationwide study
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study Open
View article: R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation Open
View article: Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders
Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders Open
Case–control observational studies suggested that aspirin might prevent hepatocellular carcinoma (HCC) in high-risk patients, even if randomized clinical trials are lacking. Information regarding aspirin in subjects who already developed H…
View article: Management of transthyretin amyloidosis
Management of transthyretin amyloidosis Open
This article was corrected and republished online on November 4, 2021. Please see Erratum (Swiss Med Wkly. 2021;151:w30104)
View article: COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study Open
Objective Explore the impact of COVID-19 on patients on the waiting list for liver transplantation (LT) and on their post-LT course. Design Data from consecutive adult LT candidates with COVID-19 were collected across Europe in a dedicated…
View article: International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria Open
Patients with more extended HCC (within the UCSF-DS protocol) successfully downstaged to the conventional Milan criteria do not have a higher recurrence rate after LT compared with the group remaining in the Milan criteria from listing to …
View article: Prenatal Screening for Developmental Displacement of the Hip: The BUDDHA (Pre-Birth Ultrasound for Developmental Displacement of the Hip Assessment) Study
Prenatal Screening for Developmental Displacement of the Hip: The BUDDHA (Pre-Birth Ultrasound for Developmental Displacement of the Hip Assessment) Study Open
Background: developmental dysplasia of the hip has an incidence of 3–5 out of 1000 children. Currently, only postnatal screening is available. Objective: to test the feasibility of a method based on Graf technique application at antenatal …
View article: Management of Acute Wilsonian Hepatitis with Severe Hemolysis: A Successful Combination of Chelation and MARS Dialysis
Management of Acute Wilsonian Hepatitis with Severe Hemolysis: A Successful Combination of Chelation and MARS Dialysis Open
Wilson’s disease is a rare hereditary disorder of copper metabolism leading to progressive accumulation of copper in several organs including the brain and the liver. Acute liver failure is a relatively rare hepatic manifestation of WD whi…
View article: Correction to: Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
Correction to: Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib Open
Clinical and Translational Gastroenterology. 2021;12(4):e00335. doi: 10.14309/ctg.0000000000000335. Original citation: Clinical and Translational Gastroenterology. 2021;12(1):e00286. doi: 10.14309/ctg.0000000000000286. Published online 14 …
View article: NAFLD and MAFLD as emerging causes of HCC: A populational study
NAFLD and MAFLD as emerging causes of HCC: A populational study Open
View article: Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib Open
INTRODUCTION: Prognostic classifications for patients treated with sorafenib for hepatocellular carcinoma (HCC) facilitate stratification in trials and inform clinical decision making. Recently, 3 different prognostic models (hepatoma arte…
View article: Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study Open
View article: On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites Open
View article: Prognostication of hepatocellular carcinoma under sorafenib: external validation of the PROSASH-II model
Prognostication of hepatocellular carcinoma under sorafenib: external validation of the PROSASH-II model Open
View article: P17.03: Ultrasound evaluation of the fetal hip: the BUDDHA study
P17.03: Ultrasound evaluation of the fetal hip: the BUDDHA study Open
Developmental displacement of the hip (DDH) is very common and early diagnosis can improve the outcome of affected babies. The objective of this study was to test the feasibility of antenatal ultrasound, using the postnatal technique based…
View article: Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial Open
View article: The conundrum of covered versus bare stents for transjugular intrahepatic portosystemic shunt: should we adopt the parachute approach?
The conundrum of covered versus bare stents for transjugular intrahepatic portosystemic shunt: should we adopt the parachute approach? Open
Transjugular intrahepatic portosystemic shunts (TIPS) are now routinely utilized for the treatment of the complications of cirrhosis-related portal hypertension: indeed TIPS has now a clear indication for active bleeding or to prevent rebl…
View article: Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC Open